Cargando…

Interrelations between Patients’ Clinicopathological Characteristics and Their Association with Response to Immunotherapy in a Real-World Cohort of NSCLC Patients

SIMPLE SUMMARY: Immunotherapy and, in particular, immune checkpoint inhibitors (ICIs), have transformed non-small cell lung cancer treatment options. Although many patients are treated with ICIs, a large number do not respond. Thus, there is a need to identify biomarkers of response. In this study,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Callejo, Ana, Frigola, Joan, Iranzo, Patricia, Carbonell, Caterina, Diaz, Nely, Marmolejo, David, Assaf, Juan David, Cedrés, Susana, Martinez-Marti, Alex, Navarro, Alejandro, Pardo, Nuria, Amat, Ramon, Felip, Enriqueta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268100/ https://www.ncbi.nlm.nih.gov/pubmed/34209601 http://dx.doi.org/10.3390/cancers13133249

Ejemplares similares

High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC
por: Frigola, Joan, et al.
Publicado: (2022)

Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohort
por: Cedres, Susana, et al.
Publicado: (2021)

Overview of Checkpoint Inhibitors Mechanism of Action: Role of Immune-Related Adverse Events and Their Treatment on Progression of Underlying Cancer
por: Iranzo, Patricia, et al.
Publicado: (2022)

Dynamic changes in circulating tumor DNA assessed by shallow whole‐genome sequencing associate with clinical efficacy of checkpoint inhibitors in NSCLC
por: Carbonell, Caterina, et al.
Publicado: (2023)

Expression of TILs and Patterns of Gene Expression from Paired Samples of Malignant Pleural Mesothelioma (MPM) Patients
por: Cedres, Susana, et al.
Publicado: (2023)

MA04.07 Clinical Characteristics and Outcomes in Patients With Malignant Pleural Mesothelioma (MPM) with COVID-19 Infection
por: Cedres, S., et al.
Publicado: (2021)

Molecular profiling of long‐term responders to immune checkpoint inhibitors in advanced non‐small cell lung cancer
por: Frigola, Joan, et al.
Publicado: (2021)

PI3K Pathway in NSCLC
por: Martinez-Martí, Alex, et al.
Publicado: (2012)

Hepatic Rupture as the Initial Presentation of an EGFR-Mutated Lung Adenocarcinoma: A Case Report
por: Mirallas, Oriol, et al.
Publicado: (2022)

Pemetrexed as second-line therapy for advanced non-small-cell lung cancer (NSCLC)
por: Felip, Enriqueta, et al.
Publicado: (2008)

Analysis of Expression of Programmed Cell Death 1 Ligand 1 (PD-L1) in Malignant Pleural Mesothelioma (MPM)
por: Cedrés, Susana, et al.
Publicado: (2015)

Fluorescence In Situ Hybridization and Immunohistochemistry as Diagnostic Methods for ALK Positive Non-Small Cell Lung Cancer Patients
por: Martinez, Pablo, et al.
Publicado: (2013)

Activity of HSP90 Inhibiton in a Metastatic Lung Cancer Patient With a Germline BRCA1 Mutation
por: Cedrés, Susana, et al.
Publicado: (2018)

Metabolic Interrelations
por: Peters, John P.
Publicado: (1955)

Dual MET and ERBB inhibition overcomes intratumor plasticity in osimertinib-resistant-advanced non-small-cell lung cancer (NSCLC)
por: Martinez-Marti, A, et al.
Publicado: (2017)

Nutrition and drug interrelations
Publicado: (1978)

Comprehensive Molecular Analysis of NSCLC; Clinicopathological Associations
por: Chatziandreou, Ilenia, et al.
Publicado: (2015)

Clinicopathological and prognostic significance of Twist overexpression in NSCLC
por: Li, Meng, et al.
Publicado: (2018)

Interrelations: the biological and physical sciences
por: Blackburn, Robert T.

Clinicopathological significance and potential drug target of T-cadherin in NSCLC
por: Wang, Zhidong, et al.
Publicado: (2014)

G.W. Leibniz, interrelations between mathematics and philosophy
por: Goethe, Norma B, et al.
Publicado: (2015)

Predicting Adolescent Depression: The Interrelated Roles of Self-Esteem and Interpersonal Stressors
por: Fiorilli, Caterina, et al.
Publicado: (2019)

Safety of Tepotinib in Patients With MET Exon 14 Skipping NSCLC and Recommendations for Management
por: Veillon, Remi, et al.
Publicado: (2022)

DSTYK inhibition increases the sensitivity of lung cancer cells to T cell–mediated cytotoxicity
por: Valencia, Karmele, et al.
Publicado: (2022)

Evaluation of clinicopathological features determining treatment response in patients with ALK mutant NSCLC
por: Dogan, Izzet, et al.
Publicado: (2022)

Clinicopathologic Characteristics and Outcomes for Patients With KRAS G12D-Mutant NSCLC
por: Cooper, Alissa J., et al.
Publicado: (2022)

Neuron-glia interrelations during phylogeny /
Publicado: (1995)

Hypertension and Depression: Interrelated Problems in Therapy
por: Simpson, F. O., et al.
Publicado: (1971)

Sarcopenia and osteoporosis are interrelated in geriatric inpatients
por: Reiss, J., et al.
Publicado: (2019)

The interrelation of COVID-19 and neurological modalities
por: Jakhmola, Shweta, et al.
Publicado: (2021)

Interrelated Oncogenic Viruses and Breast Cancer
por: Afzal, Samia, et al.
Publicado: (2022)

Interrelation of visual and olfactory impairments in schizophrenia
por: Tumova, M., et al.
Publicado: (2021)

The Interrelation between Interleukin-2 and Schizophrenia
por: Huang, Yu, et al.
Publicado: (2022)

A Delphi consensus panel about clinical management of early-stage EGFR-mutated non-small cell lung cancer (NSCLC) in Spain: a Delphi consensus panel study
por: Isla, Dolores, et al.
Publicado: (2022)

Avelumab in Combination With Cetuximab and Chemotherapy as First-Line Treatment for Patients With Advanced Squamous NSCLC
por: Andric, Zoran, et al.
Publicado: (2023)

Targeted Therapies Development in the Treatment of Advanced Nonsmall Cell Lung Cancer
por: Gridelli, Cesare, et al.
Publicado: (2011)

Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours
por: Fernandes Neto, João M., et al.
Publicado: (2020)

Emotional Distress of Patients at End-of-Life and Their Caregivers: Interrelation and Predictors
por: Soto-Rubio, Ana, et al.
Publicado: (2018)

The Gut Microbiome and Metabolites Are Altered and Interrelated in Patients With Rheumatoid Arthritis
por: Yu, Die, et al.
Publicado: (2022)

Correlation of EGFR expression, gene copy number and clinicopathological status in NSCLC
por: Gaber, Rania, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gkj3pg1u38ei349p2eqpqs35tj